The Pennant Group, Inc. (PNTG)
- Previous Close
34.68 - Open
34.73 - Bid 34.14 x 100
- Ask 34.50 x 100
- Day's Range
33.75 - 34.77 - 52 Week Range
10.31 - 37.13 - Volume
83,790 - Avg. Volume
211,571 - Market Cap (intraday)
1.035B - Beta (5Y Monthly) 2.01
- PE Ratio (TTM)
53.54 - EPS (TTM)
0.64 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.50
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
www.pennantgroup.com5,791
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PNTG
View MorePerformance Overview: PNTG
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PNTG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PNTG
View MoreValuation Measures
Market Cap
1.05B
Enterprise Value
1.40B
Trailing P/E
54.22
Forward P/E
32.15
PEG Ratio (5yr expected)
2.47
Price/Sales (ttm)
1.72
Price/Book (mrq)
6.74
Enterprise Value/Revenue
2.28
Enterprise Value/EBITDA
36.29
Financial Highlights
Profitability and Income Statement
Profit Margin
3.16%
Return on Assets (ttm)
3.58%
Return on Equity (ttm)
13.14%
Revenue (ttm)
611.81M
Net Income Avi to Common (ttm)
19.33M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
3.04M
Total Debt/Equity (mrq)
203.63%
Levered Free Cash Flow (ttm)
-479.12k